{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:03:08Z","timestamp":1794394988926,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0845-1","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:39:15Z","timestamp":1522795155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-7332","authenticated-orcid":false,"given":"Anri","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Kawanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitihiro","family":"Mitobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekiko","family":"Taneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"845_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/491709","volume":"4","author":"DP Levine","year":"2006","unstructured":"Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;4:S5\u201312.","journal-title":"Clin Infect Dis"},{"key":"845_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/AAC.23.1.138","volume":"23","author":"BF Farber","year":"1983","unstructured":"Farber BF, Moellering RC Jr. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother. 1983;23:138\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"845_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/2042018816638223","volume":"7","author":"O Bamgbola","year":"2016","unstructured":"Bamgbola O. Review of vancomycin-induced renal toxicity: an update. Ther Adv Endocrinol Metab. 2016;7:136\u201347.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"845_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s10157-011-0559-1","volume":"16","author":"NL Htike","year":"2012","unstructured":"Htike NL, Santoro J, Gilbert B, Elfenbein IB, Teehan G. Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis. Clin Exp Nephrol. 2012;16:320\u20134.","journal-title":"Clin Exp Nephrol"},{"key":"845_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0272-6386(89)80152-0","volume":"14","author":"CE Codding","year":"1989","unstructured":"Codding CE, Ramseyer L, Allon M, Pitha J, Rodriguez M. Tubulointerstitial nephritis due to vancomycin. Am J Kidney Dis. 1989;14:512\u20135.","journal-title":"Am J Kidney Dis"},{"key":"845_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1592\/phco.21.15.1233.33901","volume":"21","author":"SI Hsu","year":"2001","unstructured":"Hsu SI. Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy. 2001;21:1233\u20139.","journal-title":"Pharmacotherapy"},{"key":"845_CR7","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1007\/s00467-006-0152-0","volume":"21","author":"BA Wicklow","year":"2006","unstructured":"Wicklow BA, Ogborn MR, Gibson IW, Blydt-Hansen TD. Biopsy-proven acute tubular necrosis in a child attributed to vancomycin intoxication. Pediatr Nephrol. 2006;21:1194\u20136.","journal-title":"Pediatr Nephrol"},{"key":"845_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1345\/aph.17448","volume":"32","author":"AO Wai","year":"1998","unstructured":"Wai AO, Lo AM, Abdo A, Marra F. Vancomycin-induced acute interstitial nephritis. Ann Pharmacother. 1998;32:1160\u20134.","journal-title":"Ann Pharmacother"},{"key":"845_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/MAJ.0b013e3180a6ec1e","volume":"334","author":"S Hong","year":"2007","unstructured":"Hong S, Valderrama E, Mattana J, Shah HH, Wagner JD, Esposito M, Singhal PC. Vancomycin-induced acute granulomatous interstitial nephritis: therapeutic options. Am J Med Sci. 2007;334:296\u2013300.","journal-title":"Am J Med Sci"},{"key":"845_CR10","first-page":"139","volume":"74","author":"MN Salazar","year":"2010","unstructured":"Salazar MN, Matthews M, Posadas A, Ehsan M, Graeber C. Biopsy proven interstitial nephritis following treatment with vancomycin: a case report. Conn Med. 2010;74:139\u201341.","journal-title":"Conn Med"},{"key":"845_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MAJ.0000000000000240","volume":"347","author":"MS Gelfand","year":"2014","unstructured":"Gelfand MS, Cleveland KO, Mazumder SA. Vancomycin-induced interstitial nephritis superimposed on coexisting renal disease: the importance of renal biopsy. Am J Med Sci. 2014;347:338\u201340.","journal-title":"Am J Med Sci"},{"key":"845_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82\u201398.","journal-title":"Am J Health Syst Pharm"},{"key":"845_CR13","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/ki.2011.259","volume":"80","author":"VC Wu","year":"2011","unstructured":"Wu VC, Huang TM, Lai CF, Shiao CC, Lin YF, Chu TS, Wu PC, Chao CT, Wang JY, Kao TW, Young GH, Tsai PR, Tsai HB, Wang CL, Wu MS, Chiang WC, Tsai IJ, Hu FC, Lin SL, Chen YM, Tsai TJ, Ko WJ, Wu KD. Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int. 2011;80:1222\u201330.","journal-title":"Kidney Int"},{"key":"845_CR14","first-page":"172","volume":"33","author":"JE Geraci","year":"1958","unstructured":"Geraci JE, Heilman FR, Nichols DR, Wellman WE. Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report. Proc Staff Meet Mayo Clin. 1958;33:172\u201381.","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"845_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","volume":"68","author":"S Elyasi","year":"2012","unstructured":"Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012;68:1243\u201355.","journal-title":"Eur J Clin Pharmacol"},{"key":"845_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"K Disease","year":"2012","unstructured":"Disease K. Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney inter. 2012;2:1\u2013138.","journal-title":"Kidney inter"},{"key":"845_CR17","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute dialysis quality initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8:R204\u201312.","journal-title":"Crit Care"},{"key":"845_CR18","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute kidney injury network. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.","journal-title":"Crit Care"},{"key":"845_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/FTD.0000000000000250","volume":"38","author":"M Haeseker","year":"2016","unstructured":"Haeseker M, Croes S, Neef C, Bruggeman C, Stolk L, Verbon A. Evaluation of vancomycin prediction methods based on estimated creatinine clearance or trough levels. Ther Drug Monit. 2016;38:120\u20136.","journal-title":"Ther Drug Monit"},{"key":"845_CR20","doi-asserted-by":"publisher","first-page":"e99044","DOI":"10.1371\/journal.pone.0099044","volume":"9","author":"ZK Ye","year":"2014","unstructured":"Ye ZK, Li C, Zhai SD. Guidelines for therapeutic drug monitoring of vancomycin: a systematic review. PLoS One. 2014;9:e99044.","journal-title":"PLoS One"},{"key":"845_CR21","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"845_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.chest.2017.05.011","volume":"152","author":"K Jin","year":"2017","unstructured":"Jin K, Murugan R, Sileanu FE, Foldes E, Priyanka P, Clermont G, Kellum JA. Intensive monitoring of urine output is associated with increased detection of acute kidney injury and improved outcomes. Chest. 2017;152:972\u20139.","journal-title":"Chest"},{"key":"845_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/030097498440886","volume":"27","author":"S Michail","year":"1998","unstructured":"Michail S, Vaiopoulos G, Nakopoulou L, et al. Henoch-Schoenlein purpura and acute interstitial nephritis after intravenous vancomycin administration in a patient with a staphylococcal infection. Scand J Rheumatol. 1998;27:233\u20135.","journal-title":"Scand J Rheumatol"},{"key":"845_CR24","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/ndt\/gfh170","volume":"19","author":"H Sokol","year":"2004","unstructured":"Sokol H, Vigneau C, Maury E, Guidet B, Offenstadt G. Biopsy-proven anuric acute tubular necrosis associated with vancomycin and one dose of aminoside. Nephrol Dial Transplant. 2004;19:1921\u20132.","journal-title":"Nephrol Dial Transplant"},{"key":"845_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/08860220701643773","volume":"29","author":"CY Wu","year":"2007","unstructured":"Wu CY, Wang JS, Chiou YH, Chen CY, Su YT. Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review. Ren Fail. 2007;29:1059\u201361.","journal-title":"Ren Fail"},{"key":"845_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tox.2005.07.009","volume":"215","author":"F Oktem","year":"2005","unstructured":"Oktem F, Arslan MK, Ozguner F, Candir O, Yilmaz HR, Ciris M, Uz E. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology. 2005;215:227\u201333.","journal-title":"Toxicology"},{"key":"845_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxlet.2017.05.023","volume":"277","author":"DS Im","year":"2017","unstructured":"Im DS, Shin HJ, Yang KJ, Jung SY, Song HY, Hwang HS, Gil HW. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein. Toxicol Lett. 2017;277:9\u201317.","journal-title":"Toxicol Lett"},{"key":"845_CR28","first-page":"327","volume":"17","author":"R Azar","year":"1996","unstructured":"Azar R, Bakhache E, Boldron A. Acute interstitial nephropathy induced by vancomycin. Nephrologie. 1996;17:327\u20138.","journal-title":"Nephrologie"},{"key":"845_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/phar.1442","volume":"34","author":"LD Burgess","year":"2014","unstructured":"Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy. 2014;34:670\u20136.","journal-title":"Pharmacotherapy"},{"key":"845_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/phar.1428","volume":"34","author":"D Gomes","year":"2014","unstructured":"Gomes D, Smotherman C, Birch A, Dupree L, Della Vecchia BJ, Kraemer DF, Jankowski CA. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy. 2014;34:662\u20139.","journal-title":"Pharmacotherapy"},{"key":"845_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/jac\/25.4.679","volume":"25","author":"M Rybak","year":"1990","unstructured":"Rybak M, Albrecht L, Boike S, Chandrasekar P. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother. 1990;25:679\u201387.","journal-title":"J Antimicrob Chemother"},{"key":"845_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijantimicag.2008.02.004","volume":"32","author":"HM Lode","year":"2008","unstructured":"Lode HM. Rational antibiotic therapy and the position of ampicillin\/sulbactam. Int J Antimicrob Agents. 2008;32:10\u201328.","journal-title":"Int J Antimicrob Agents"},{"key":"845_CR33","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1517\/17425250903145251","volume":"5","author":"AP Betrosian","year":"2009","unstructured":"Betrosian AP, Douzinas EE. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. Expert Opin Drug Metab Toxicol. 2009;5:1099\u2013112.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"845_CR34","doi-asserted-by":"crossref","unstructured":"Stidham T, Reiter PD, Ford DM, Lum GM, Albietz J. Successful utilization of high-flux hemodialysis for treatment of vancomycin toxicity in a child. Case Rep Pediatr. 2011;2011:678724.","DOI":"10.1155\/2011\/678724"},{"key":"845_CR35","first-page":"23","volume-title":"Vancomycin: a comprehensive review of 30 years clinical experience","author":"GL Cooper","year":"1986","unstructured":"Cooper GL, Given DB. Vancomycin: a comprehensive review of 30 years clinical experience. San Diego, CA, USA: Park Row Publishers; 1986. p. 23\u201338."},{"key":"845_CR36","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1128\/AAC.01674-10","volume":"55","author":"JM Butterfield","year":"2011","unstructured":"Butterfield JM, Patel N, Pai MP, Rosano TG, Drusano GL, Lodise TP. Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding. Antimicrob Agents Chemother. 2011;55:4277\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"845_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0272-6386(12)70298-6","volume":"20","author":"CA DeSoi","year":"1992","unstructured":"DeSoi CA, Sahm DF, Umans JG. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes. Am J Kidney Dis. 1992;20:354\u201360.","journal-title":"Am J Kidney Dis"},{"key":"845_CR38","first-page":"51","volume":"50","author":"EF Foote","year":"1998","unstructured":"Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA. Pharmacokinetics of vancomycin when administered during high flux hemodialysis. Clin Nephrol. 1998;50:51\u20135.","journal-title":"Clin Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0845-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-0845-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0845-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T20:22:18Z","timestamp":1553631738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0845-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0845-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"19 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"72"}}